✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Legend Biotech Corp

Common Name
Legend Biotech
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
2,900
Ticker
LEGN
Exchange
NASDAQ/NGS
Description
Legend Biotech Corporation is a global biotechnology company primarily focused on the discovery and development of innovative cellular therapies. Its primary function centers around utilizing cutting-...

Legend Biotech's GHG Emissions Data Preview

In 2024, Legend Biotech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Legend Biotech has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)202420232022
2021 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
0000000
Total Scope 2
Market-Based
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
0000000
Location-Based
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
0000000
Total Scope 3
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
0000000
Limited Data Preview
You are viewing a limited preview of Legend Biotech’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2023, and revenue-based intensity metrics for each scope.
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=LEGN&reporting_period=2024"

Verified Sources Behind Legend Biotech’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Legend Biotech’s data sources below and access millions more through our Disclosure Search.

a. Legend Biotech's ESG Report 2024
b. Legend Biotech's ESG Report 2023

Insights into Legend Biotech's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Legend Biotech amounted to 12,090 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Legend Biotech decreased by 8.39%, showing that the company has made progress in taking action to reduce the climate impact of its operations.ab

Legend Biotech's Scope 1 Emissions Over Time

202320240200400600800tCO2e0%
  • Total Scope 1
  • Year-over-Year Change

What are Legend Biotech's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Legend Biotech were 769 metric tons of CO₂ equivalent (tCO₂e).a

Compared to the previous year (2023), Legend Biotech's Scope 1 emissions remained relatively stable, indicating that Legend Biotech's emissions have plateaued with no significant change in its operational footprint.ab

What are Legend Biotech's Scope 2 emissions?

In 2024, Legend Biotech reported Scope 2 greenhouse gas (GHG) emissions of 11,945 tCO₂e using the market-based method and 11,321 tCO₂e using the location-based method.a

Has Legend Biotech reduced its Scope 2 emissions over time?

Compared to the previous year (2023), Legend Biotech's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Legend Biotech's emissions have plateaued with no significant change in its energy consumption footprint.ab

What methodology does Legend Biotech use for Scope 2 reporting?

In 2024, Legend Biotech reported its Scope 2 emissions using the market-based method and using the location-based method.a

Legend Biotech's Scope 2 Emissions Over Time

2023202403.5 k7 k10.5 k14 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Legend Biotech’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Legend Biotech reported Scope 1 greenhouse gas (GHG) emissions of 769 tCO₂e and total revenues of USD 627 millions. This translates into an emissions intensity of 1.23 tCO₂e per millions USD.a

Legend Biotech's Scope 1 Emissions Intensity Compared to Peers

2501,00010,000200,000Scope 1 Emissions (tCO2e)101005005,00050,000Revenues (Millions of USD)FCIncyteYear: 2024Scope 1: 9,576 tCO2eRevenue: $M 4,241Scope 1 Intensity: 2.26 tCO2e/$MBio-TechneYear: 2023Scope 1: 3,001 tCO2eRevenue: $M 1,137Scope 1 Intensity: 2.64 tCO2e/$MInsmedYear: 2024Scope 1: 1,666 tCO2eRevenue: $M 364Scope 1 Intensity: 4.58 tCO2e/$MBio Rad LaboratoriesYear: 2023Scope 1: 10,563 tCO2eRevenue: $M 2,671Scope 1 Intensity: 3.95 tCO2e/$MFFFortrea HoldingsYear: 2023Scope 1: 864 tCO2eRevenue: $M 3,109Scope 1 Intensity: 0.28 tCO2e/$MFrontage HoldingsYear: 2023Scope 1: 2,883 tCO2eRevenue: $M 2,027Scope 1 Intensity: 1.42 tCO2e/$MR1 RCM HoldcoYear: 2023Scope 1: 676 tCO2eRevenue: $M 2,254Scope 1 Intensity: 0.30 tCO2e/$MRegeneron PharmaceuticalsYear: 2024Scope 1: 80,300 tCO2eRevenue: $M 14,202Scope 1 Intensity: 5.65 tCO2e/$MHalozyme TherapeuticsYear: 2024Scope 1: 1,348 tCO2eRevenue: $M 1,015Scope 1 Intensity: 1.33 tCO2e/$MPrestige Consumer HealthcareYear: 2021Scope 1: 1,304 tCO2eRevenue: $M 943Scope 1 Intensity: 1.38 tCO2e/$MModernaYear: 2024Scope 1: 13,180 tCO2eRevenue: $M 3,199Scope 1 Intensity: 4.12 tCO2e/$MSarepta TherapeuticsYear: 2023Scope 1: 3,428 tCO2eRevenue: $M 1,243Scope 1 Intensity: 2.76 tCO2e/$MMerit Medical SystemsYear: 2024Scope 1: 2,875 tCO2eRevenue: $M 1,357Scope 1 Intensity: 2.12 tCO2e/$MSotera HealthYear: 2023Scope 1: 39,206 tCO2eRevenue: $M 1,049Scope 1 Intensity: 37.36 tCO2e/$MCytokineticsYear: 2024Scope 1: 242 tCO2eRevenue: $M 18Scope 1 Intensity: 13.10 tCO2e/$MAlnylam PharmaceuticalsYear: 2024Scope 1: 3,832 tCO2eRevenue: $M 2,248Scope 1 Intensity: 1.70 tCO2e/$MCCCatalyst PharmaceuticalsYear: 2024Scope 1: 4 tCO2eRevenue: $M 493Scope 1 Intensity: 0.01 tCO2e/$MEnvista HoldingsYear: 2024Scope 1: 3,000 tCO2eRevenue: $M 2,511Scope 1 Intensity: 1.19 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MIonis PharmaceuticalsYear: 2024Scope 1: 2,616 tCO2eRevenue: $M 705Scope 1 Intensity: 3.71 tCO2e/$MVertex PharmaceuticalsYear: 2024Scope 1: 8,976 tCO2eRevenue: $M 11,020Scope 1 Intensity: 0.81 tCO2e/$MLegend BiotechYear: 2024Scope 1: 769 tCO2eRevenue: $M 627Scope 1 Intensity: 1.23 tCO2e/$M

How does Legend Biotech's GHG emissions intensity compare to its peers?

In 2024, Legend Biotech reported a Scope 1 emissions intensity of 1.23 tCO₂e per millions USD. Compared to the peer group median of 2.26, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Legend Biotech rank on GHG emissions intensity within its industry?

In 2024, Legend Biotech ranked 6 out of 21 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

Legend Biotech is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Want Full Access to Legend Biotech's GHG Emissions Dataset?
Sign Up